SCHEMBL4154199

SCHEMBL4154199

CSc1ccc(N(C)C(=O)NC(=O)c2c(F)cccc2F)c(F)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.38
NPC1 O15118 2/20 0.38
PKM P14618 1/20 0.38
PPIA P62937 2/20 0.37
USP2 O75604 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
RORC P51449 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ATM Q13315 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
HTT P42858 1/20 0.33
NOD2 Q9HC29 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4154082 0.92 RORC (0.43) RAB9APKMPPIARORCKMT2A
SCHEMBL4157944 0.87 RORC (0.40) RAB9ANPC1PKMPPIAUSP2
SCHEMBL4157453 0.87 TRPA1 (0.36) RAB9ANPC1PKMPPIARORC
SCHEMBL4158996 0.87 TRPA1 (0.34) RAB9ANPC1PKMPPIARORC
SCHEMBL4148300 0.87 ATM (0.45) RAB9ANPC1PKMPPIASMN1; SMN2
SCHEMBL4151007 0.85 TRPA1 (0.33) RAB9ANPC1PKMPPIAUSP2
SCHEMBL4160195 0.84 TRPA1 (0.35) RAB9ANPC1KDM4EALDH1A1RORC
SCHEMBL13774520 0.83 MEN1 (0.41) RAB9APPIARORCMEN1KMT2A
SCHEMBL4145038 0.83 ATM (0.35) RAB9ANPC1PKMPPIAUSP2
SCHEMBL4150582 0.83 RORC (0.34) RAB9ANPC1PKMPPIARORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 RAB9A 642/4885NPC1 1869/4885PKM 3145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.